The Annual Report for 2021, including Report of the Board of Directors and Financial Statements, will be published on Solteq's website by March 2, 2022.
The Annual General Meeting is planned to be held in Vantaa on March 24, 2022. The Board of Directors will convene the meeting separately at a later date.
Solteq is a Nordic provider of IT services and software solutions specializing in the digitalization of business and industry-specific software. The key sectors in which the company has long term experience include retail, manufacturing, energy and services. The company operates in Finland, Sweden, Norway, Denmark, Poland, and the UK and employs over 650 professionals.
TetraScience and Databricks today announced a strategic partnership dedicated to helping life sciences organizations harness Scientific AI to bring more effective and safer therapies to market faster and less expensively.
The life sciences industry...
Jenne, Inc., one of the nation's premier value-added technology solutions distributors and cloud services brokerage, today announced that it is partnering with i-PRO Co., Ltd. (formerly Panasonic Security), a global leader in professional security...
Pager, Inc., a leading digital healthcare enablement and care advocacy company serving 28 million members in the United States and Latin America, and AXA Partners Mexico (APM) today announced a strategic partnership that provides new capabilities to...
G Medical Innovations Holdings Ltd. (GMVD), a telehealth, medical device, and remote patient monitoring company, announced today a Partnership with Peter N Nielsen to Drive Health and Wellness Innovation. G Medical, a leading provider of innovative...
RentSpree, the leading provider of rental software in the U.S., today announced that UtahRealEstate.com (URE), a multiple listing service providing software and services to approximately 20,000 real estate professionals, has joined its 300-strong...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Atara...
